drugset / Trial / NCT07649070

Phase 2 Trial of G207 + 5 Gy Radiation for Children With High-Grade Gliomas

NCT07649070 ↗

Phase 2 Not yet recruiting 38 enrolled M.D. Anderson Cancer Center
NaSingle-groupOpen-labelTreatment

Summary

The goal of this clinical research study is to learn about the safety and effects of G207 combined with radiation therapy in patients with recurrent or progressive high-grade glioma (HGG).

Timeline

Start
2026-11-30
Primary completion
2030-12-31
Completion
2032-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject G207 Other / unclassified — Other

Indications